Navigation Links
Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Date:6/24/2008

Partners Expect Program to Advance to the Clinic Within a Year; Studies

Generate Milestone Payment to Micromet

BETHESDA, Md., and ZURICH, Switzerland, June 24 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI) and Nycomed today announced the initiation of formal preclinical safety studies for the anti-GM-CSF human antibody MT203. Micromet received $775,000 (500,000 euros) from Nycomed for the achievement of this milestone.

Under a 2007 agreement between the two companies, Micromet and Nycomed develop MT203, a fully human anti-GM-CSF antibody that may be useful for the treatment of various inflammatory and autoimmune diseases. Preclinical studies support MT203's development for the treatment of rheumatoid arthritis and several other indications, including multiple sclerosis, psoriasis, asthma and chronic obstructive pulmonary disease.

"Data on MT203 remain encouraging and we are pleased to reach this important developmental milestone," said Jens Hennecke, Micromet's Vice President of Business Development. "The MT203 program is well on track and we are looking forward to advancing it into the clinic within a year."

"Within our partnership, Micromet has continued to deliver encouraging data on MT203 related to the treatment of inflammatory and autoimmune diseases," said Anders Ullman, Nycomed's Executive Vice President Research and Development. "MT203 represents an important asset in our early stage pipeline."

About Nycomed (http://www.nycomed.com)

Nycomed is a privately owned pharmaceutical company that provides medicines for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. It
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "Market ... and Europe" report to their offering. ,     ... analysis of the respiratory imaging diagnostics market in ... Europe . The service provides ...
(Date:5/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that its Board of Directors has ... 2015 of $0.03 per share of common stock outstanding.  ... be paid on June 19, 2015 to all common ... ex-dividend date for the quarterly dividend is June 10, ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4United States and Europe Respiratory Diagnostics Market Assessment 2015 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
(Date:5/24/2015)... May 24, 2015 For people who ... Chinese Enterokinase Industry, 2009-2019 Market Research Report would be ... an exhaustive study on the present market scenario of ... into the growing Chinese market of this industry. The ... overall status of the manufacturers in this industry. The ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 ... Branches Florida City exactly five years to the day after ... , A large fire tore through the Branches United Methodist ... in the middle of the night as neighbors, staff and ... arson even though it is suspected that the fire began ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 On May 16, ... MuckFest. The event was a 5k mud obstacle run that ... than 2 million people worldwide, and the reason we participated ... said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent ... Sclerosis Society.” , The event was not only attended by ...
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today on the proposed ... but which has not been signed to date by Governor ... with overwhelming bipartisan support on April 10, 2015, and ... bill ensures that fracking is prohibited in Maryland through October ... fracking to our water supplies and the air we breathe,” ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3
... University at Buffalo researcher John Violanti, Ph.D., a ... conduct a study on suicide risk among returning veterans. ... the number of soldiers taking their own lives., Violanti ... how quickly persons associate feelings of self-harm, as a ...
... 6 Masimo Corporation (Nasdaq: MASI ), ... Low-Perfusion pulse oximetry, today announced that its management is ... Annual OC Growth Stock Conference at The Ritz-Carlton, Laguna ... 2009, at 11:00 a.m. PT. A live audiocast of ...
... 6 Optimal Reading Services Group, Inc., ... and radiology group practices, announced that its chief executive ... Global Healthcare Services Conference on Monday, February 9, 2009 ... in New York City.Optimal leverages a deep pool of ...
... Study finds great inactivity and little encouragement for kids ... -- Even when they,re playing outside, children tend not ... says. , In fact, the researchers found that ... 5-year-olds was found to be sedentary at community-based preschool ...
... PA -- For years controversy has surrounded whether electronic ... cut medical errors, and reduce healthcare costs. Now, researchers ... discovered a way to get another bonus from the ... treatments for disease. , In the first ...
... VOLC ), a leader in the development, manufacturing ... coronary and peripheral artery,disease, today announced that it will ... of fiscal 2008 on Tuesday, February 17. , ... call to discuss its financial results,and operating activities open ...
Cached Medicine News:Health News:Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2Health News:Optimal Readings to Present at 2009 UBS Global Healthcare Services Conference 2Health News:For Preschoolers, Even 'Play' Tends to Be Sedentary 2Health News:Penn study shows how electronic medical records can be used to test drug efficacy 2Health News:Penn study shows how electronic medical records can be used to test drug efficacy 3Health News:Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast 2
... RELISA ENA Single Well Screening Kit is designed ... most common autoantibodies. Each microtiter well is coated ... autoantigens. This allows the laboratory to cost effectively ... to determining the ENA specificity on any of ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
... Lipid Control is intended for use in ... sample of known concentration for monitoring assay ... Liquid Lipid Control with patient serum specimens ... constituents. The user can compare observations with ...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Medicine Products: